Gene · 3802
Papers2,190
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
221 to 240 of 2,190
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Highly Multiplexed Spatially Resolved Proteomic and Transcriptional Profiling of the Glioblastoma Microenvironment Using Archived Formalin-Fixed Paraffin-Embedded Specimens. | Mod Pathol | 2023 | 36788070 | PubTator, text mining | PubMed |
| Bioinformatic Analysis of PTTG Family and Prognosis and Immune Cell Infiltration in Gastric Cancer. | Stem Cells Int | 2023 | 36785594 | PubTator, text mining | PubMed |
| Identification of tumor antigens and immune subtypes of acute myeloid leukemia for mRNA vaccine development. | Clin Transl Oncol | 2023 | 36781600 | PubTator, text mining | PubMed |
| The Role of Platelets in the Pathogenesis and Pathophysiology of Adenomyosis. | J Clin Med | 2023 | 36769489 | PubTator, text mining | PubMed |
| Hypermethylated WASF2: tumor suppressive role in head and neck squamous cell carcinoma. | Transl Cancer Res | 2023 | 36760387 | PubTator, text mining | PubMed |
| Clusterin is a biomarker of breast cancer prognosis and correlated with immune microenvironment. | Transl Cancer Res | 2023 | 36760385 | PubTator, text mining | PubMed |
| NK cell education: Physiological and pathological influences. | Front Immunol | 2023 | 36742337 | PubTator, text mining | PubMed |
| Significance of logistic regression scoring model based on natural killer cell-mediated cytotoxic pathway in the diagnosis of colon cancer. | Front Immunol | 2023 | 36742322 | PubTator, text mining | PubMed |
| [Correlation between gene polymorphisms of killer cell immunoglobulin-like receptors and their ligands and Graves' disease]. | Zhonghua Yi Xue Za Zhi | 2023 | 36740392 | PubTator, text mining | PubMed |
| PRR11 is a prognostic biomarker and correlates with immune infiltrates in bladder urothelial carcinoma. | Sci Rep | 2023 | 36739300 | PubTator, text mining | PubMed |
| Myelodysplastic Syndrome associated TET2 mutations affect NK cell function and genome methylation. | Nat Commun | 2023 | 36737440 | PubTator, text mining | PubMed |
| FMO rewires metabolism to promote longevity through tryptophan and one carbon metabolism in C. elegans. | Nat Commun | 2023 | 36732543 | PubTator, text mining | PubMed |
| Innate receptors modulating adaptive T cell responses: KIR-HLA interactions and T cell-mediated control of chronic viral infections. | Immunogenetics | 2023 | 36719466 | PubTator, text mining | PubMed |
| PLEKHA4 Is a Prognostic Biomarker and Correlated with Immune Infiltrates in Glioma. | Biomed Res Int | 2023 | 36714030 | PubTator, text mining | PubMed |
| The role of the HLA allelic repertoire on the clinical severity of COVID-19 in Canadians, living in the Saskatchewan province. | Hum Immunol | 2023 | 36707385 | PubTator, text mining | PubMed |
| Malaria-driven expansion of adaptive-like functional CD56-negative NK cells correlates with clinical immunity to malaria. | Sci Transl Med | 2023 | 36696483 | PubTator, text mining | PubMed |
| Large case-control study indicates no association of KIR genotype and risk of developing acute myeloid leukemia. | Blood Adv | 2023 | 36689727 | PubTator, text mining | PubMed |
| ARHGAP21 Is Involved in the Carcinogenic Mechanism of Cholangiocarcinoma: A Study Based on Bioinformatic Analyses and Experimental Validation. | Medicina (Kaunas) | 2023 | 36676763 | PubTator, text mining | PubMed |
| Exploring the potential of combining IL-2-activated NK cells with an anti-PDL1 monoclonal antibody to target multiple myeloma-associated macrophages. | Cancer Immunol Immunother | 2023 | 36656341 | PubTator, text mining | PubMed |
| Monoclonal Gammopathies and the Bone Marrow Microenvironment: From Bench to Bedside and Then Back Again. | Hematol Rep | 2023 | 36648882 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3802/papers?page=12